piperacillin has been researched along with Neoplasms in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (24.00) | 18.7374 |
| 1990's | 17 (22.67) | 18.2507 |
| 2000's | 15 (20.00) | 29.6817 |
| 2010's | 20 (26.67) | 24.3611 |
| 2020's | 5 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cuellar-Pompa, L; Lede, R; Rosanova, MT | 1 |
| Albertsen, BK; Friberg, LE; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M | 1 |
| Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Charoenkwan, P; Choeyprasert, W; Fanhchaksai, K; Kamonrattana, R; Natesirinilkul, R; Sathitsamitphong, L | 1 |
| Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH | 1 |
| Becker, SL; Egle, L; Graf, N; Haber, M; Ockfen, S; Sauter, K; Simon, A; Wagenpfeil, G | 1 |
| Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
| Bandettini, R; Barco, S; Cangemi, G; Castagnola, E; Mesini, A; Saffioti, C | 1 |
| Brock, B; Friberg, LE; Kristoffersson, AN; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M | 1 |
| Burke, MJ; Pratt, JA; Stricherz, MK; Verghese, PS | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Arda, B; Nazli-Zeka, A; Ozkoren-Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T | 1 |
| Arisoy, ES; Corapcioglu, F; Demirsoy, U; Karadogan, M; Karakurt, DG; Oncel, S | 1 |
| Acipayam, C; Bayram, I; Ozkan, A; Sezgin, G; Tanyeli, A | 1 |
| Cies, JJ; Jain, J; Kuti, JL | 1 |
| Abu-Seir, H; Gregg, KS; Hough, SM; Marini, BL; Nagel, JL | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Fukuta, F; Hashimoto, J; Hashimoto, K; Hiyama, Y; Ichihara, K; Kobayashi, K; Masumori, N; Muranaka, T; Niiyama, Y; Takahashi, S; Yamakage, M | 1 |
| Cho, SY; Chung, DR; Ha, YE; Jung, CW; Kang, CI; Kang, ES; Ko, JH; Lee, JY; Lee, WJ; Peck, KR; Song, JH | 1 |
| Emiroğlu, M; Köksal, Y; Köse, D | 1 |
| Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
| Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
| Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M | 1 |
| Gomi, H; Miura, Y; Morisawa, Y; Sugano, K; Yokota, K | 1 |
| Mayumi, M; Takeuchi, M; Tanizawa, A | 1 |
| Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S | 1 |
| Glasmacher, A; Wade, JC | 1 |
| Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
| Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K | 1 |
| Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C | 1 |
| Bordigoni, P; Chastagner, P; Fouyssac, F; Mansuy, L; Salmon, A; Schmitt, C | 1 |
| Bellaire, T; Cornely, OA; Dörken, B; Einsele, H; Krause, S; Kubin, T; Maschmeyer, G; Reich, G; Sandherr, M; Thiel, E | 1 |
| Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G | 1 |
| Bode, U; Fleischhack, G; Groll, AH; Laws, HJ; Lehrnbecher, T; Molitor, E; Simon, A; Tramsen, L; Wieland, R | 1 |
| Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM | 1 |
| Klastersky, J | 1 |
| Fennelly, JJ; Kelly, DA | 1 |
| Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K | 1 |
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| Calandra, T; Cometta, A; de Bock, R; Gaya, H; Glauser, MP; Klastersky, J; Langenaeken, J; Paesmans, M; Viscoli, C; Zinner, S | 1 |
| Abs, L; Bekradda, M; Culine, S; Droz, JP; Farhat, F; Kattan, J | 1 |
| Bodey, GP; Dholakia, N; Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| De Pauw, BE; Deresinski, SC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
| Brown, BW; Finley, RS; Joshi, JH; Moody, MA; Newman, KA; Ruxer, RL; Schimpff, SC | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Carlisle, P; Cimino, M; Gucalp, R; Roberts, J; Rotstein, C; Yamamura, D | 1 |
| Böhme, C; Hess, U; Rey, K; Senn, HJ | 1 |
| Halbur, SR; Postelnick, M | 1 |
| Francis, L; Henry, RL; Jones, PD; Stuart, J | 1 |
| Bradley, SJ | 1 |
| Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E | 1 |
| Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B | 1 |
| Ahonen, J; Jahkola, M; Kontiainen, S; Paavonen, J; Renkonen, OV; Ruutu, P; Skogberg, K; Syrjänen, J; Valtonen, V | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Drusano, GL | 1 |
| Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH | 1 |
| Spencer, RC; Taylor, AK; Winfield, DA | 1 |
| Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
| Drusano, GL; Forrest, A; Plaisance, KI; Wade, JC | 1 |
| Allerberger, F; Ausserer, B; Fink, FM; Frischhut-Schiffer, EM; Guggenbichler, JP | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Bodey, GP; Elting, L; Ho, DH | 1 |
| Anaissie, EJ; Bodey, GP; Cabanillas, F; Elting, L; Fainstein, V; Kantarjian, H; McCredie, KB; Rolston, K | 1 |
| Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
| Ameglio, F; Casali, A; Gallo Curcio, C; Gionfra, T; Paoletti, G; Tonachella, R | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
| Bernstein, JM; Brummett, RE; Gorse, GJ; Levin, RD; Linzmayer, MI; Lorber, RR; Markowitz, N; Pegram, PS; Saravolatz, LD | 1 |
| Clavell, LA; González, M | 1 |
| Drusano, GL; Forrest, A; Joshi, J; Leslie, J; Ruxer, R; Schimpff, S; Standiford, H; Wade, J | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Sakurai, M; Sampi, K | 1 |
4 review(s) available for piperacillin and Neoplasms
| Article | Year |
|---|---|
[Efficacy and safety of empirical treatment with piperacillin/tazobactan as monotherapy in episodes of neutropenia and fever in children with cancer: systematic review and meta-analysis].
Topics: Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin | 2021 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2005 |
Pharmacologic considerations with antimicrobials used in oncology.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Humans; Immunocompromised Host; Neoplasms; Opportunistic Infections; Piperacillin | 1998 |
40 trial(s) available for piperacillin and Neoplasms
| Article | Year |
|---|---|
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Male; Neoplasms; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome | 2019 |
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome | 2020 |
Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytokines; Female; Fever; Humans; Infant; Inflammation Mediators; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Risk Factors | 2014 |
Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Female; Fever; Humans; Male; Models, Biological; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Severity of Illness Index; Sulbactam | 2009 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors | 2012 |
Piperacillin plus aztreonam for treatment of neutropenic fever.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Piperacillin | 2003 |
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2003 |
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin | 2004 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins | 2004 |
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome | 2005 |
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Thienamycins | 2005 |
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2008 |
Evaluation of piperacillin sodium in the treatment of infections in immune compromised patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Immunologic Deficiency Syndromes; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Sepsis | 1982 |
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin | 1981 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 1995 |
Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
Topics: Adult; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Odds Ratio; Piperacillin; Superinfection; Tobramycin; Treatment Outcome | 1994 |
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacteremia; Ceftazidime; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Fever; Granulocytes; Humans; Incidence; Leukocyte Count; Logistic Models; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Serum Bactericidal Test; Superinfection; Tobramycin | 1993 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.
Topics: Adult; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin | 1997 |
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome | 1998 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam | 2001 |
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome | 2001 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies | 1991 |
A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed septicaemia.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteria; Drug Therapy, Combination; Female; Gentamicins; Glycopeptides; Humans; Leukemia; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Sepsis; Teicoplanin | 1990 |
A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Statistics as Topic | 1989 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Vancomycin | 1988 |
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Random Allocation | 1987 |
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation | 1987 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients.
Topics: Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Hearing Loss; Humans; Immune Tolerance; Infections; Middle Aged; Neoplasms; Netilmicin; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1986 |
Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.
Topics: Adolescent; Adult; Aged; Animals; Cattle; Ceftazidime; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Neoplasms; Piperacillin; Tobramycin | 1985 |
31 other study(ies) available for piperacillin and Neoplasms
| Article | Year |
|---|---|
Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
Topics: Anti-Bacterial Agents; Body Weight; Child; Febrile Neutropenia; Fever; Humans; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2022 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |
Meropenem Use in Pediatric Oncology - Audit on Indication, Appropriateness and Consumption Comparing Patient Derived and Pharmacy Dispensing Data.
Topics: Anti-Bacterial Agents; Child; Humans; Meropenem; Neoplasms; Penicillanic Acid; Pharmacy; Piperacillin; Retrospective Studies | 2021 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
Piperacillin-tazobactam concentration target attainment in children with cancer.
Topics: Child; Fever; Humans; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2019 |
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Fever; Glomerular Filtration Rate; Humans; Infant; Male; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2019 |
Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Diseases; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sulbactam; Treatment Outcome | 2014 |
Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Humans; Infant; Male; Meropenem; Neoplasms; Neutrophils; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thienamycins; Young Adult | 2014 |
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Young Adult | 2015 |
Serum antimicrobial concentrations for surgical antimicrobial prophylaxis in radical nephrectomy and radical prostatectomy.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefazolin; Female; Half-Life; Humans; Kidney; Male; Middle Aged; Neoplasms; Nephrectomy; Piperacillin; Prospective Studies; Prostate; Prostatectomy; Surgical Wound Infection; Urologic Surgical Procedures | 2015 |
Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Fungal; Aspergillosis; Case-Control Studies; False Positive Reactions; Female; Galactose; Humans; Male; Mannans; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Time Factors | 2015 |
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors | 2015 |
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
Cholangitis with septic shock caused by Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; Cholangitis; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Shock, Septic; Treatment Outcome | 2012 |
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome | 2006 |
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey.
Topics: Bacterial Infections; Fever of Unknown Origin; Humans; Hypersensitivity; Infant; Infant, Newborn; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2007 |
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin | 1982 |
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin | 1984 |
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Sulbactam; Vancomycin | 1994 |
In vitro activity of FK-037, a novel parenteral cephalosporin, against bacterial isolates from neutropenic cancer patients.
Topics: Aztreonam; Bacteria; Ceftazidime; Ceftizoxime; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Piperacillin | 1994 |
Suspected infection in children with cancer.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Bacteriuria; Catheterization, Central Venous; Child; Child, Preschool; Clinical Protocols; Drug Resistance, Microbial; Feces; Fever; Floxacillin; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infant; Leukocyte Count; Methicillin Resistance; Neoplasms; Neutrophils; Penicillin Resistance; Penicillins; Piperacillin; Pulse; Retrospective Studies; Skin; Staphylococcal Infections; Tobramycin | 1998 |
Control of glycopeptide-resistant enterococci in an oncology unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2000 |
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aspartate Aminotransferases; Bacteremia; Blood Sedimentation; Child; Child, Preschool; Diabetes Complications; Drug Therapy, Combination; Female; Gastroenteritis; Humans; Immunosuppression Therapy; Infant; Infant, Newborn; Kidney Transplantation; Listeriosis; Meningitis, Listeria; Middle Aged; Neoplasms; Penicillin G; Piperacillin; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome | 1992 |
Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.
Topics: Bayes Theorem; Ceftazidime; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic Fibrosis; Fever; Humans; Models, Theoretical; Monte Carlo Method; Neoplasms; Neutropenia; Pharmacokinetics; Piperacillin; Population; Sampling Studies; Weightlessness | 1991 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
[Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
Topics: Adolescent; Agranulocytosis; Antineoplastic Agents; Cefamandole; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gentamicins; Humans; Infant; Infusion Pumps; Leukocyte Count; Male; Neoplasms; Neutropenia; Piperacillin; Sepsis | 1989 |
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins | 1988 |
Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Humans; Neoplasms; Neutropenia; Piperacillin; Prospective Studies | 1987 |
[Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin | 1985 |